•   
  •   

US News COVID-19: lapel for AstraZeneca in the development of a treatment

22:25  15 june  2021
22:25  15 june  2021 Source:   lepoint.fr

Coronavirus: Astrazeneca says that its vaccine is effective against the Variant Delta

 Coronavirus: Astrazeneca says that its vaccine is effective against the Variant Delta health-coronavirus-astrazeneca-vaccine: coronavirus: astrazeneca says that its vaccine is effective against the Variant Delta © Reuters / Henry Nicholls Coronavirus: Astrazeneca says that his Vaccine is effective against the Variant Delta (Reuters) - AstraZeneca announced Tuesday that its VVID-19 vaccine was effective against the Delta and Kappa variants of the coronavirus, which were detected first in India, citing a study conducted by The British University of Oxford.

AstraZeneca, covid-19, vaccin © provided by the point AstraZeneca, Covid-19, Vaccine

L are bad news is accumulating for AstraZeneca. The Anglo-Swedish pharmaceutical group announced Tuesday to have undergone a setback in the development of a treatment for CVIV-19, whose effectiveness on persons exposed to the virus has not been proven. It is an antibody treatment, whose code name is AZD7442 and which must allow both to prevent and treat the disease. "The test has not achieved the main purpose of preventing cases of symptomatic COVID-19 after exposure" to the virus, "said AstraZeneca in a statement.

The treatment was in phase 3 of development, that is to say in large-scale clinical trials to measure its safety and effectiveness. The 1,121 participants were adults over 18 who were not vaccinated and have been exposed to a contaminated person during the previous eight days. Treatment has reduced the risk of developing a CVIV-19 with symptoms than 33%. Tests continue to evaluate the remedy on patients before exposure to the virus, and for those who have developed severe forms.

Coronavirus: Nearly 40 countries unable to continue vaccinating for lack of doses

 Coronavirus: Nearly 40 countries unable to continue vaccinating for lack of doses "We have a huge number of countries that had to suspend their campaign," said Dr. Bruce Aylward from WHO © Rajanish Kakade the campaign Vaccination against COVID-19 in India, here in Bombay. PANDEMIE - "We have a huge number of countries that had to suspend their campaign," said Dr. Bruce Aylward from WHO countries that are particularly in sub-Saharan Africa, but also in Latin America, In the Middle East and South Asia, including the neighbors of India like Nepal or Sri Lanka ...

to read also a dose of Astrazeneca, another of Pfizer? And if you take a vaccine cocktail?


video: AstraZeneca vaccine: France records four new cases of thromboses, including two deaths (capital)

Starries on vaccine

The development of this treatment is funded by the US government, which In return had concluded agreements with Astrazeneca to receive up to 700,000 doses this year. In total, the value of the agreements with the United States for the development of treatment and doses in 2021 reached $ 726 million. In its statement, AstraZeneca indicates that discussions are under way "concerning the next steps with the US government". AstraZeneca is always confronted with interrogations on its VVID-19 vaccine, suspended by several European countries after rare blood problems in vaccinated persons.

The Pandemic of Covid-19 had a "considerable" impact on minorities and young people in Europe

 The Pandemic of Covid-19 had a © AFP / Oliver Bunic A migrant from Afghanistan receiving a dose of Astrazeneca in Obrenovac, Serbia, the March 29, 2021. Employment, Health ... According to a European report, the Pandemic of Covid-19 has exacerbated inequalities towards minorities and young people. Among the first line categories, the elderly, children, roma, refugees and migrants, or the disabled.

to read also 100,000 people under 55 years old vaccinated at Astrazeneca since March

a senior official of the European Medicines Agency (EMA) even went so far as to estimate that it would be better to stop The AstraZeneca vaccine against COVID-19 for all age groups, including for more than 60 years, when alternatives are available . But the EMA denied and explained Tuesday that the words of Marco Cavaleri in the newspaper La Stampa Sunday had been misinterpreted. "It is clear that the risk-risk ratio for individuals over 60 is even better", according to a spokesman. At the same time, a study published Monday by the British health authorities revealed that two doses of the Pfizer -Biontech or AstraZeneca / Oxford vaccines protect to more than 90% against hospitalizations after contracted the coronavirus delta variant, initially appeared. In India .

COVID-19: how to recover your European sanitary pass to travel this summer .
© DR / European Union, 2021 The European digital certificate certifies with a QR code of protection against CVIV-19. (Illustration) Dr A step closer to the holidays under other heavens. The "EU digital COVID" , which will fluidify the controls of the health status and exempt quarantine, is available this Friday on the Health Insurance website dedicated to vaccination, Ameli.fr .

usr: 1
This is interesting!